Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB102-DQA105 and TNF -308A

The overlap between genetic susceptibility to celiac disease (CD) and to type 1 diabetes is incomplete; therefore, some genetic polymorphisms may significantly modify the risk of CD in subjects with type 1 diabetes. This study aimed to investigate whether the susceptibility to CD in diabetic childre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2006-04, Vol.29 (4), p.858-863
Hauptverfasser: Sumnik, Zdenek, Cinek, Ondrej, Bratanic, Nina, Kordonouri, Olga, Kulich, Michal, Roszai, Barnabas, Arato, Andras, Lebl, Jan, Soltesz, Gyula, Danne, Thomas, Battelino, Tadej, Schober, Edit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 863
container_issue 4
container_start_page 858
container_title Diabetes care
container_volume 29
creator Sumnik, Zdenek
Cinek, Ondrej
Bratanic, Nina
Kordonouri, Olga
Kulich, Michal
Roszai, Barnabas
Arato, Andras
Lebl, Jan
Soltesz, Gyula
Danne, Thomas
Battelino, Tadej
Schober, Edit
description The overlap between genetic susceptibility to celiac disease (CD) and to type 1 diabetes is incomplete; therefore, some genetic polymorphisms may significantly modify the risk of CD in subjects with type 1 diabetes. This study aimed to investigate whether the susceptibility to CD in diabetic children is modified by positivity for HLA-DQB1*02-DQA1*05 and DQB1*0302-DQA1*03 and by alleles of single nucleotide polymorphisms within the genes encoding CTLA4, transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-1, IL-2, IL-6, and IL-10. Genotypic data were compared between 130 case subjects (children with type 1 diabetes and CD diagnosed using endomysium antibodies) and 245 control subjects (children with type 1 diabetes only, optimally two per case, matched for center, age at type 1 diabetes onset, and type 1 diabetes duration). The subjects were recruited from 10 major European pediatric diabetes centers performing regular screening for CD. The polymorphisms were determined using PCR with sequence-specific primers, and the risk was assessed by building a step-up conditional logistic regression model using variables that were significantly associated with CD in the univariate analysis. The best-fitted model showed that risk of CD is increased by presence of HLA-DQB1*02-DQA1*05 (odds ratio 4.5 [95% CI 1.8-11], for homozygosity, and 2.0 [1.1-3.7], for a single dose) and also independently by TNF -308A (1.9 [1.1-3.2], for phenotypic positivity), whereas IL1-alpha -889T showed a weak negative association (0.6 [0.4-0.9]). The results indicate that the risk of CD in children with type 1 diabetes is significantly modified both by the presence of HLA-DQB1*02-DQA1*05 and by a variant of another gene within the major histocompatibility complex, the TNF -308A.
doi_str_mv 10.2337/diacare.29.04.06.dc05-1923
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67799075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1021684581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-c2e9d85d2479afec0318e156b0fabe0b14f92c5f3a1081ad62375df5b4e094943</originalsourceid><addsrcrecordid>eNpdkU9v1DAQxS0EokvhKyCrB24J43-JzW0pLa20AoHK2XLsseqymyx2AtpvX6-6ElJP7zBvZt7Mj5ALBi0Xov8YkvMuY8tNC7KFrg0eVMMMFy_IihmhGqWkfklWwKRplDH8jLwp5QEApNT6NTljnep6zfWKLD9T-U2nSD1u61gaUkFXkKaR-vu0DRlH-i_N93Q-7JGyWncDzlhoKnQ3hRQTBjoc6H4qaU5_03ygccr0ZrNuvvz4zIBXWTNQ1I2B3n27po0AvX5LXkW3LfjupOfk1_XV3eVNs_n-9fZyvWm8kHJuPEcTtApc9sZF9CCYRqa6AWJNAQOT0XCvonAMNHOh46JXIapBIhhppDgnH57m7vP0Z8Ey210q9dKtG3Faiu363hjoVTVePDM-TEseazbLuQDR1b9X06cnk89TKRmj3ee0c_lgGdgjGXsiY7mxIC109kjGHsnU5venDcuww_C_9YRCPALm1Yme</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223036337</pqid></control><display><type>article</type><title>Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB102-DQA105 and TNF -308A</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Sumnik, Zdenek ; Cinek, Ondrej ; Bratanic, Nina ; Kordonouri, Olga ; Kulich, Michal ; Roszai, Barnabas ; Arato, Andras ; Lebl, Jan ; Soltesz, Gyula ; Danne, Thomas ; Battelino, Tadej ; Schober, Edit</creator><creatorcontrib>Sumnik, Zdenek ; Cinek, Ondrej ; Bratanic, Nina ; Kordonouri, Olga ; Kulich, Michal ; Roszai, Barnabas ; Arato, Andras ; Lebl, Jan ; Soltesz, Gyula ; Danne, Thomas ; Battelino, Tadej ; Schober, Edit</creatorcontrib><description>The overlap between genetic susceptibility to celiac disease (CD) and to type 1 diabetes is incomplete; therefore, some genetic polymorphisms may significantly modify the risk of CD in subjects with type 1 diabetes. This study aimed to investigate whether the susceptibility to CD in diabetic children is modified by positivity for HLA-DQB1*02-DQA1*05 and DQB1*0302-DQA1*03 and by alleles of single nucleotide polymorphisms within the genes encoding CTLA4, transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-1, IL-2, IL-6, and IL-10. Genotypic data were compared between 130 case subjects (children with type 1 diabetes and CD diagnosed using endomysium antibodies) and 245 control subjects (children with type 1 diabetes only, optimally two per case, matched for center, age at type 1 diabetes onset, and type 1 diabetes duration). The subjects were recruited from 10 major European pediatric diabetes centers performing regular screening for CD. The polymorphisms were determined using PCR with sequence-specific primers, and the risk was assessed by building a step-up conditional logistic regression model using variables that were significantly associated with CD in the univariate analysis. The best-fitted model showed that risk of CD is increased by presence of HLA-DQB1*02-DQA1*05 (odds ratio 4.5 [95% CI 1.8-11], for homozygosity, and 2.0 [1.1-3.7], for a single dose) and also independently by TNF -308A (1.9 [1.1-3.2], for phenotypic positivity), whereas IL1-alpha -889T showed a weak negative association (0.6 [0.4-0.9]). The results indicate that the risk of CD in children with type 1 diabetes is significantly modified both by the presence of HLA-DQB1*02-DQA1*05 and by a variant of another gene within the major histocompatibility complex, the TNF -308A.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.29.04.06.dc05-1923</identifier><identifier>PMID: 16567828</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Adolescent ; Case-Control Studies ; Celiac disease ; Celiac Disease - complications ; Celiac Disease - genetics ; Celiac Disease - immunology ; Child ; Children &amp; youth ; Diabetes ; Diabetes Mellitus, Type 1 - complications ; Diabetes Mellitus, Type 1 - genetics ; Diabetes Mellitus, Type 1 - immunology ; Female ; Genetic Predisposition to Disease ; Genetic research ; Genotype ; Genotype &amp; phenotype ; HLA-DQ alpha-Chains ; HLA-DQ Antigens - genetics ; HLA-DQ beta-Chains ; Humans ; Male ; Phenotype ; Regression Analysis ; Risk Factors ; Tumor Necrosis Factor-alpha - genetics</subject><ispartof>Diabetes care, 2006-04, Vol.29 (4), p.858-863</ispartof><rights>Copyright American Diabetes Association Apr 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-c2e9d85d2479afec0318e156b0fabe0b14f92c5f3a1081ad62375df5b4e094943</citedby><cites>FETCH-LOGICAL-c344t-c2e9d85d2479afec0318e156b0fabe0b14f92c5f3a1081ad62375df5b4e094943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16567828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sumnik, Zdenek</creatorcontrib><creatorcontrib>Cinek, Ondrej</creatorcontrib><creatorcontrib>Bratanic, Nina</creatorcontrib><creatorcontrib>Kordonouri, Olga</creatorcontrib><creatorcontrib>Kulich, Michal</creatorcontrib><creatorcontrib>Roszai, Barnabas</creatorcontrib><creatorcontrib>Arato, Andras</creatorcontrib><creatorcontrib>Lebl, Jan</creatorcontrib><creatorcontrib>Soltesz, Gyula</creatorcontrib><creatorcontrib>Danne, Thomas</creatorcontrib><creatorcontrib>Battelino, Tadej</creatorcontrib><creatorcontrib>Schober, Edit</creatorcontrib><title>Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB102-DQA105 and TNF -308A</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>The overlap between genetic susceptibility to celiac disease (CD) and to type 1 diabetes is incomplete; therefore, some genetic polymorphisms may significantly modify the risk of CD in subjects with type 1 diabetes. This study aimed to investigate whether the susceptibility to CD in diabetic children is modified by positivity for HLA-DQB1*02-DQA1*05 and DQB1*0302-DQA1*03 and by alleles of single nucleotide polymorphisms within the genes encoding CTLA4, transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-1, IL-2, IL-6, and IL-10. Genotypic data were compared between 130 case subjects (children with type 1 diabetes and CD diagnosed using endomysium antibodies) and 245 control subjects (children with type 1 diabetes only, optimally two per case, matched for center, age at type 1 diabetes onset, and type 1 diabetes duration). The subjects were recruited from 10 major European pediatric diabetes centers performing regular screening for CD. The polymorphisms were determined using PCR with sequence-specific primers, and the risk was assessed by building a step-up conditional logistic regression model using variables that were significantly associated with CD in the univariate analysis. The best-fitted model showed that risk of CD is increased by presence of HLA-DQB1*02-DQA1*05 (odds ratio 4.5 [95% CI 1.8-11], for homozygosity, and 2.0 [1.1-3.7], for a single dose) and also independently by TNF -308A (1.9 [1.1-3.2], for phenotypic positivity), whereas IL1-alpha -889T showed a weak negative association (0.6 [0.4-0.9]). The results indicate that the risk of CD in children with type 1 diabetes is significantly modified both by the presence of HLA-DQB1*02-DQA1*05 and by a variant of another gene within the major histocompatibility complex, the TNF -308A.</description><subject>Adolescent</subject><subject>Case-Control Studies</subject><subject>Celiac disease</subject><subject>Celiac Disease - complications</subject><subject>Celiac Disease - genetics</subject><subject>Celiac Disease - immunology</subject><subject>Child</subject><subject>Children &amp; youth</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 1 - complications</subject><subject>Diabetes Mellitus, Type 1 - genetics</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic research</subject><subject>Genotype</subject><subject>Genotype &amp; phenotype</subject><subject>HLA-DQ alpha-Chains</subject><subject>HLA-DQ Antigens - genetics</subject><subject>HLA-DQ beta-Chains</subject><subject>Humans</subject><subject>Male</subject><subject>Phenotype</subject><subject>Regression Analysis</subject><subject>Risk Factors</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU9v1DAQxS0EokvhKyCrB24J43-JzW0pLa20AoHK2XLsseqymyx2AtpvX6-6ElJP7zBvZt7Mj5ALBi0Xov8YkvMuY8tNC7KFrg0eVMMMFy_IihmhGqWkfklWwKRplDH8jLwp5QEApNT6NTljnep6zfWKLD9T-U2nSD1u61gaUkFXkKaR-vu0DRlH-i_N93Q-7JGyWncDzlhoKnQ3hRQTBjoc6H4qaU5_03ygccr0ZrNuvvz4zIBXWTNQ1I2B3n27po0AvX5LXkW3LfjupOfk1_XV3eVNs_n-9fZyvWm8kHJuPEcTtApc9sZF9CCYRqa6AWJNAQOT0XCvonAMNHOh46JXIapBIhhppDgnH57m7vP0Z8Ey210q9dKtG3Faiu363hjoVTVePDM-TEseazbLuQDR1b9X06cnk89TKRmj3ee0c_lgGdgjGXsiY7mxIC109kjGHsnU5venDcuww_C_9YRCPALm1Yme</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>Sumnik, Zdenek</creator><creator>Cinek, Ondrej</creator><creator>Bratanic, Nina</creator><creator>Kordonouri, Olga</creator><creator>Kulich, Michal</creator><creator>Roszai, Barnabas</creator><creator>Arato, Andras</creator><creator>Lebl, Jan</creator><creator>Soltesz, Gyula</creator><creator>Danne, Thomas</creator><creator>Battelino, Tadej</creator><creator>Schober, Edit</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20060401</creationdate><title>Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB102-DQA105 and TNF -308A</title><author>Sumnik, Zdenek ; Cinek, Ondrej ; Bratanic, Nina ; Kordonouri, Olga ; Kulich, Michal ; Roszai, Barnabas ; Arato, Andras ; Lebl, Jan ; Soltesz, Gyula ; Danne, Thomas ; Battelino, Tadej ; Schober, Edit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-c2e9d85d2479afec0318e156b0fabe0b14f92c5f3a1081ad62375df5b4e094943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Case-Control Studies</topic><topic>Celiac disease</topic><topic>Celiac Disease - complications</topic><topic>Celiac Disease - genetics</topic><topic>Celiac Disease - immunology</topic><topic>Child</topic><topic>Children &amp; youth</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 1 - complications</topic><topic>Diabetes Mellitus, Type 1 - genetics</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic research</topic><topic>Genotype</topic><topic>Genotype &amp; phenotype</topic><topic>HLA-DQ alpha-Chains</topic><topic>HLA-DQ Antigens - genetics</topic><topic>HLA-DQ beta-Chains</topic><topic>Humans</topic><topic>Male</topic><topic>Phenotype</topic><topic>Regression Analysis</topic><topic>Risk Factors</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sumnik, Zdenek</creatorcontrib><creatorcontrib>Cinek, Ondrej</creatorcontrib><creatorcontrib>Bratanic, Nina</creatorcontrib><creatorcontrib>Kordonouri, Olga</creatorcontrib><creatorcontrib>Kulich, Michal</creatorcontrib><creatorcontrib>Roszai, Barnabas</creatorcontrib><creatorcontrib>Arato, Andras</creatorcontrib><creatorcontrib>Lebl, Jan</creatorcontrib><creatorcontrib>Soltesz, Gyula</creatorcontrib><creatorcontrib>Danne, Thomas</creatorcontrib><creatorcontrib>Battelino, Tadej</creatorcontrib><creatorcontrib>Schober, Edit</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sumnik, Zdenek</au><au>Cinek, Ondrej</au><au>Bratanic, Nina</au><au>Kordonouri, Olga</au><au>Kulich, Michal</au><au>Roszai, Barnabas</au><au>Arato, Andras</au><au>Lebl, Jan</au><au>Soltesz, Gyula</au><au>Danne, Thomas</au><au>Battelino, Tadej</au><au>Schober, Edit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB102-DQA105 and TNF -308A</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>29</volume><issue>4</issue><spage>858</spage><epage>863</epage><pages>858-863</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>The overlap between genetic susceptibility to celiac disease (CD) and to type 1 diabetes is incomplete; therefore, some genetic polymorphisms may significantly modify the risk of CD in subjects with type 1 diabetes. This study aimed to investigate whether the susceptibility to CD in diabetic children is modified by positivity for HLA-DQB1*02-DQA1*05 and DQB1*0302-DQA1*03 and by alleles of single nucleotide polymorphisms within the genes encoding CTLA4, transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-1, IL-2, IL-6, and IL-10. Genotypic data were compared between 130 case subjects (children with type 1 diabetes and CD diagnosed using endomysium antibodies) and 245 control subjects (children with type 1 diabetes only, optimally two per case, matched for center, age at type 1 diabetes onset, and type 1 diabetes duration). The subjects were recruited from 10 major European pediatric diabetes centers performing regular screening for CD. The polymorphisms were determined using PCR with sequence-specific primers, and the risk was assessed by building a step-up conditional logistic regression model using variables that were significantly associated with CD in the univariate analysis. The best-fitted model showed that risk of CD is increased by presence of HLA-DQB1*02-DQA1*05 (odds ratio 4.5 [95% CI 1.8-11], for homozygosity, and 2.0 [1.1-3.7], for a single dose) and also independently by TNF -308A (1.9 [1.1-3.2], for phenotypic positivity), whereas IL1-alpha -889T showed a weak negative association (0.6 [0.4-0.9]). The results indicate that the risk of CD in children with type 1 diabetes is significantly modified both by the presence of HLA-DQB1*02-DQA1*05 and by a variant of another gene within the major histocompatibility complex, the TNF -308A.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>16567828</pmid><doi>10.2337/diacare.29.04.06.dc05-1923</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2006-04, Vol.29 (4), p.858-863
issn 0149-5992
1935-5548
language eng
recordid cdi_proquest_miscellaneous_67799075
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adolescent
Case-Control Studies
Celiac disease
Celiac Disease - complications
Celiac Disease - genetics
Celiac Disease - immunology
Child
Children & youth
Diabetes
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 1 - genetics
Diabetes Mellitus, Type 1 - immunology
Female
Genetic Predisposition to Disease
Genetic research
Genotype
Genotype & phenotype
HLA-DQ alpha-Chains
HLA-DQ Antigens - genetics
HLA-DQ beta-Chains
Humans
Male
Phenotype
Regression Analysis
Risk Factors
Tumor Necrosis Factor-alpha - genetics
title Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB102-DQA105 and TNF -308A
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T05%3A11%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20celiac%20disease%20in%20children%20with%20type%201%20diabetes%20is%20modified%20by%20positivity%20for%20HLA-DQB102-DQA105%20and%20TNF%20-308A&rft.jtitle=Diabetes%20care&rft.au=Sumnik,%20Zdenek&rft.date=2006-04-01&rft.volume=29&rft.issue=4&rft.spage=858&rft.epage=863&rft.pages=858-863&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.29.04.06.dc05-1923&rft_dat=%3Cproquest_cross%3E1021684581%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223036337&rft_id=info:pmid/16567828&rfr_iscdi=true